ONGOING PHASE 1B/2 TRIALS OF MOSUNETUZUMAB INVESTIGATING NOVEL TREATMENT REGIMENS FOR PATIENTS WITH B‐CELL NON‐HODGKIN LYMPHOMA (NHL). (12th June 2019)

• Record Type: Journal Article
• Authors: Budde, L.E.; Vallurupalli, A.; Babu, S.; Lossos, I.S.; Alderuccio, J.P.; Chavez, J.C.; Eradat, H.; Holmes, H.; Hamadani, M.; Karur, V.G.; Olszewski, A.J.; Seymour, E.; Althaus, B.; Medeiros, B.M.; Li, C.C.; Kwan, A.; Wei, M.C.; Yin, S.; O'Hear, C.; Munoz, J.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 564
• Page End: 566
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.12_2632
• Languages: English
• ISSNs: 0278-0232